about
Emerging preclinical pharmacological targets for Parkinson's diseaseDiabetes and risk of Parkinson's disease: a systematic review and meta-analysisPolychlorinated biphenyls in prospectively collected serum and Parkinson's disease riskNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersParkinson's disease or Parkinson symptoms following seasonal influenza.The rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitryParkinsonism in patients with a history of amphetamine exposure.Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's diseaseDepression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study.Association of cumulative lead exposure with Parkinson's disease.The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.The effects of aging vs. α7 nAChR subunit deficiency on the mouse brain transcriptome: aging beats the deficiency.Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.The adverse effects of air pollution on the nervous system.The potential of induced pluripotent stem cells as a translational model for neurotoxicological riskClinical approach to Parkinson's disease: features, diagnosis, and principles of management.Risk factors for Parkinson's disease may differ in men and women: an exploratory study.Metabolic markers or conditions preceding Parkinson's disease: a case-control study.Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.Artistic occupations are associated with a reduced risk of Parkinson's diseaseThe role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.Pharmacological therapy in Parkinson's disease: focus on neuroprotection.The role of phytochemicals in the treatment and prevention of dementia.Targeting nicotinic receptors for Parkinson's disease therapy.Medicinal plants and dementia therapy: herbal hopes for brain aging?Parkinson's disease: considerations for dental hygienists.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.Airborne nanoparticles (PM0.1 ) induce autophagic cell death of human neuronal cells.Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan.The impact of genetic research on our understanding of Parkinson's diseaseModulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson's Disease.Optimizing disease progression study designs for drug effect discrimination.Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease.Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?
P2860
Q26764724-7F24D62D-8557-47F1-BCD8-2E1B05B702B6Q26849796-B34ECF5B-004A-4E1F-8305-3D9CE0E5B185Q28391573-93EE41F8-D833-47AC-AD15-B9D2832584B1Q29615839-65F56C30-BE03-486B-AAB6-F3A2C22E111FQ30403795-22196332-DB61-49C2-8F99-32BFCAE38568Q33613315-DDDD04F7-7C69-465D-8FD3-E7B9D835F5BAQ33698983-CC06B1D7-C7B3-48A3-92DE-BB9C39A27F1BQ33889585-429537E2-6A10-41BD-BCF5-AD5B79E1C705Q33890060-D0ADB1BA-BDE6-4960-8435-84697E1BDF13Q33958143-F0A550B0-0D75-47BE-9CA7-BD057AD07206Q34038382-25265DD0-5CE6-4908-906E-27AEA3412457Q34282891-F13C9C7D-0E30-4FF0-94E0-04D034D2994EQ34428287-1C0EFB7F-B83E-4BA4-8A4E-5948EBA320ACQ34714815-CD43D774-CB8C-47A7-9361-B3747B546DBCQ34793270-D3B0672B-EDB3-461B-810D-1427E2CDD7AFQ34865706-F20FBCDC-BDC9-40E3-83A8-DBFA80CD8D03Q35264378-220DB35F-717F-437A-81EC-B5FB9A7BE127Q35276597-B78DAB03-8D97-4B87-877A-56440FCFEB85Q35864850-7537015A-4F5B-43FA-9F90-00279101A0DBQ35981667-86860184-0250-4931-AECC-262ABC762143Q36009241-2BF2236E-74DF-4233-9938-37F0D6E51771Q36335715-A198F230-F399-4A20-BA93-9F09E4E026FDQ36516892-1F6B2002-5695-483E-B19E-8AC38F7ED021Q36617859-B9CE5C8B-4A70-4C57-8D18-9095522EDB5CQ36621598-840275CB-4B94-441D-A443-00E2563E9740Q37278592-C0D43148-56F3-4ABD-8CCC-5BEF3DC5B32AQ37741285-59210571-C30F-4793-9912-22008A99A629Q37884566-FF1AEBCE-E005-4A6A-9C78-4F9AFBA76BF7Q37916643-56BFF0FE-7129-42E5-87EA-5A2BA2C1C62CQ37954368-2DF9780C-B87D-48C0-BAB1-CC8F6CDD89FCQ37994890-5BB1ACF0-DCBD-4876-BD6E-6F792ACD5EE2Q38532889-85323130-706E-46DC-998F-7A5DAC25E5CEQ38629277-92324A86-1FFF-43BE-932C-6F0958EBC202Q38778128-B7D57229-EC2A-453F-9C76-09FB2E89C19EQ38823617-793EAD66-5B09-4EF5-BE8A-FDE43C3DC89CQ41525066-B06049FC-25FD-4D06-83E1-F4AA7D128F38Q42180022-82D5B078-CC0B-4A14-BE81-533530D4687DQ43837566-CCA1980F-E8CD-4343-9A39-183EFD82155EQ45820322-E505BD69-83BA-45B5-AEA7-603D2A64A62AQ47239603-E226A1A2-B44B-4F5D-B15E-CB925B5D4C98
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update in the epidemiology of Parkinson's disease.
@en
Update in the epidemiology of Parkinson's disease.
@nl
type
label
Update in the epidemiology of Parkinson's disease.
@en
Update in the epidemiology of Parkinson's disease.
@nl
altLabel
Update in the epidemiology of Parkinsonʼs disease
@en
prefLabel
Update in the epidemiology of Parkinson's disease.
@en
Update in the epidemiology of Parkinson's disease.
@nl
P1476
Update in the epidemiology of Parkinson's disease.
@en
P2093
Alexis Elbaz
P304
P356
10.1097/WCO.0B013E3283050461
P50
P577
2008-08-01T00:00:00Z